| 产品标题 |
产品货号 |
产品规格 |
厂家 |
| Human N-ethylmaleimide-sensitive factor attachment protein, alpha (NAPA) from ORIGENE TECHNOLOGIES | TP307037 | 20 ug | ORIGENE TECHNOLOGIES |
| Human N-ethylmaleimide-sensitive factor attachment protein, beta (NAPB) from ORIGENE TECHNOLOGIES | TP309278 | 20 ug | ORIGENE TECHNOLOGIES |
| Human N-ethylmaleimide-sensitive factor attachment protein, gamma (NAPG) from ORIGENE TECHNOLOGIES | TP300450 | 20 ug | ORIGENE TECHNOLOGIES |
| Human N-ethylmaleimide-sensitive factor (NSF) from ORIGENE TECHNOLOGIES | TP305983 | 20 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIES | CR562573 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIES | CR562613 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIES | CR562577 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIES | CR562616 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIES | CR562650 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIES | CR562645 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIES | CR562656 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIES | CR562659 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIES | CR562665 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIES | CR562696 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIES | CR562745 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIES | CR562746 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIES | CR562778 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIES | CR562801 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIES | CR562784 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIES | CR562857 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIES | CR562863 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIES | CR562867 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIES | CR562901 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIES | CR562868 | 5 ug | ORIGENE TECHNOLOGIES |
| Fatty acid synthase (FASN) from ORIGENE TECHNOLOGIES | LY418211 | 100 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIES | CR562913 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIES | CR562983 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIES | CR562957 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIES | CR563014 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIES | CR562955 | 5 ug | ORIGENE TECHNOLOGIES |
| Ldlr - mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN309204 | 1 kit | ORIGENE TECHNOLOGIES |
| Ldlr - mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN309204BN | 1 kit | ORIGENE TECHNOLOGIES |
| Ldlr - mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN309204LP | 1 kit | ORIGENE TECHNOLOGIES |
| Ldlr - mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN309204RB | 1 kit | ORIGENE TECHNOLOGIES |
| Alpha 1, 4-galactosyltransferase (A4GALT) from ORIGENE TECHNOLOGIES | LY402588 | 100 ug | ORIGENE TECHNOLOGIES |
| Human alkB, alkylation repair homolog 2 (E. coli) (ALKBH2), transcript variant 3 from ORIGENE TECHNOLOGIES | TP326527 | 20 ug | ORIGENE TECHNOLOGIES |
| Human alkB, alkylation repair homolog 6 (E. coli) (ALKBH6), transcript variant 2 from ORIGENE TECHNOLOGIES | TP324553 | 20 ug | ORIGENE TECHNOLOGIES |
| Human alkB, alkylation repair homolog 6 (E. coli) (ALKBH6), transcript variant 1 from ORIGENE TECHNOLOGIES | TP321937 | 20 ug | ORIGENE TECHNOLOGIES |
| Human Lung: left lower lobe; Emphysema from ORIGENE TECHNOLOGIES | CS544868 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Lung: left lower lobe; Emphysema from ORIGENE TECHNOLOGIES | CS544870 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Lung: left lower lobe; Emphysema from ORIGENE TECHNOLOGIES | CS814509 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Lung: left lower lobe; Emphysema from ORIGENE TECHNOLOGIES | CS814510 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Lung: left lower lobe; Emphysema from ORIGENE TECHNOLOGIES | CS814512 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Lung: left lower lobe; Emphysema from ORIGENE TECHNOLOGIES | CS814513 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Lung: left lower lobe; Emphysema from ORIGENE TECHNOLOGIES | CS814511 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Lung: left lower lobe; Emphysema, centrilobular from ORIGENE TECHNOLOGIES | CS549419 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Lung: left lower lobe; Emphysematous changes from ORIGENE TECHNOLOGIES | CS715808 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Lung: left lower lobe, normal from ORIGENE TECHNOLOGIES | CS706500 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Lung: left lower lobe; Emphysema from ORIGENE TECHNOLOGIES | CS814516 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Lung: left lower lobe, normal from ORIGENE TECHNOLOGIES | CS706501 | 5x5um | ORIGENE TECHNOLOGIES |